ENLV icon

Enlivex Therapeutics

17 hedge funds and large institutions have $2.96M invested in Enlivex Therapeutics in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$54K
Puts
$22K
Net Calls
Net Calls Change

Top Buyers

1 +$2.41M
2 +$245K
3 +$35.2K
4
Goldman Sachs
Goldman Sachs
New York
+$16.2K
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.56K

Top Sellers

1 -$258K
2 -$210K
3 -$69K
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$9.83K
5
UBS Group
UBS Group
Switzerland
-$4.39K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.41M
2
$348K
3
$102K
4
$35.2K
5
$16.2K
6
$14.8K
7
$13K
8
$8.16K
9
$4.26K
10
$1.42K
11
$874
12
$568
13
$328
14
$213
15
$23
16
$16
17
$1
18
19
20
21